IFITM1 and non-small cell lung carcinoma: The results validated that co-transfection with wild-type1 (WT1) or wild-type2 (WT2) but not mutant-type1(MuT1) or mutant-type2 (MuT2) IFITM1 reporters led to significantly decreased luciferase activities in NSCLC cells, which demonstrated that miR-147a could directly target IFITM1 in NSCLC cells (Figures 6F,G).